Seeing Is Believing

Currently out of the existing stock ratings of Elemer Piros, 197 are a BUY (84.55%), 20 are a HOLD (8.58%), 16 are a SELL (6.87%).
Analyst Elemer Piros, carries an average stock price target met ratio of 34.89% that have a potential upside of 61.79% achieved within 234 days. Previously, Elemer Piros worked at BENCHMARK.
Elemer Piros’s has documented 456 price targets and ratings displayed on 51 stocks. The coverage was on Healthcare, Industrials sectors.
Most recent stock forecast was given on INMB, INmune Bio at 11-Mar-2026.
Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for ARCT (ARCTURUS THERAPEUTICS HOLDINGS) at 3/2/2021. The price target of $45 was fulfilled within 3 days with a profit of $8.96 (16.6%) receiving and performance score of 55.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Oct-2017
$20
$15.71 (366.20%)
$20
13 days ago
(19-Mar-2026)
0/15 (0%)
$15.46 (340.53%)
Buy Since 29-Apr-2025
$19
$14.71 (342.89%)
$20
4 months 20 days ago
(12-Nov-2025)
0/3 (0%)
$14.06 (284.62%)
Buy Since 02-Jun-2025
$20
$15.71 (366.20%)
$19
7 months 17 days ago
(15-Aug-2025)
0/2 (0%)
$12.87 (180.50%)
Buy Since 30-May-2024
$20
$15.55 (349.44%)
$21
10 months 16 days ago
(16-May-2025)
0/2 (0%)
$13.9 (227.87%)
Buy Since 19-Feb-2025
$15
$10.71 (249.65%)
$15
1 years 8 days ago
(24-Mar-2025)
0/2 (0%)
$9.88 (192.97%)
Which stock is Elemer Piros is most bullish on?
Which stock is Elemer Piros is most reserved on?
What Year was the first public recommendation made by Elemer Piros?